Back to results
US 2011/0301170 A1Published application
Inhibitors of JNK
OwnerLeyi Gong, Yun-Chou Taninventors
Life of this patent
Estimating the term…
Abstract
Compounds of formula I or pharmaceutically acceptable salts thereof, wherein: wherein m, n, p, q, X Y, Z, A, R1, R2, R3, R4, R5 and Y6 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity.
Claims19
A compound of formula I
- or pharmaceutically acceptable salts thereof,
- wherein:
- m is from 0 to 2;
- n is from 0 to 2;
- p is from 0 to 3;
- q is from 0 to 2;
- X is:
- CH;
- or N;
- Y is:
- CRa;
- or N;
- wherein Ra is:
- hydrogen;
- C1-6alkyl;
- or —C(O)—NH2;
- Z is:
- CRb;
- or N;
- wherein Rb is:
- hydrogen;
- C1-6alkyl;
- or halo-C1-6alkyl;
- each R1 is independently :
- hydrogen;
- or C1-6alkyl;
- A is CRb;
- or N;
- each R2 is independently:
- C1-6alkyl;
- C1-6alkoxy;
- halo;
- halo-C1-6alkyl;
- or halo-C1-6alkoxy;
- R3 is:
- hydrogen;
- halo;
- C1-6alkyl;
- halo-C1-6alkyl;
- halo-C1-6alkoxy;
- C1-6alkenyl;
- hydroxy-C1-6alkyl;
- C1-6alkylsulfonyl-C1-6alkoxy;
- tetrahydrothiophenyl-1,1-oxide-C1-6alkoxy;
- tetrahydrothiopyran-1,1-oxide-C1-6alkoxy;
- or piperidinyl optionally substituted with C1-6alkylsulfonyl;
- each R4 is independently:
- C1-6alkyl;
- C1-6alkoxy;
- halo;
- halo-C1-6alkyl;
- or halo-C1-6alkoxy;
- each R5 is independently:
- hydrogen;
- or C1-6alkyl;
- and
- R6 is:
- hydrogen;
- C1-6alkyl;
- or halo-C1-6alkyl.
57 more elements
Dependencies are inferred from the claim text.